{"id":"https://openalex.org/W7165452002","doi":"https://doi.org/10.82351/wajp.vol29no2.465","title":"Cost of illness analysis of Human Immuno-deficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) in a developing economy","display_name":"Cost of illness analysis of Human Immuno-deficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) in a developing economy","alternate_titles":[],"publication_year":2026,"publication_date":"2026-06-01","ids":{"openalex":"https://openalex.org/W7165452002","doi":"https://doi.org/10.82351/wajp.vol29no2.465"},"language":"en","primary_location":{"id":"doi:10.82351/wajp.vol29no2.465","doi":"https://doi.org/10.82351/wajp.vol29no2.465","is_oa":true,"landing_page_url":"https://doi.org/10.82351/wajp.vol29no2.465","pdf_url":null,"source":{"id":"https://openalex.org/S7407060212","display_name":"West African Journal of Pharmacy","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4391012544","host_organization_name":"Afrischolar Discovery Initiative","host_organization_lineage":["https://openalex.org/I4391012544"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"parent_works":[],"lineage":["https://openalex.org/W7165452002"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.82351/wajp.vol29no2.465","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045826026","display_name":"Abdulganiyu Giwa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134542131","display_name":"University of Ilorin","ror":"https://ror.org/032kdwk38","country_code":"NG","type":"education","lineage":["https://openalex.org/I134542131"]}],"countries":["NG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giwa, Abdulganiyu","raw_affiliation_strings":["Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, University of Ilorin, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, University of Ilorin, Nigeria","institution_ids":["https://openalex.org/I134542131"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139029340","display_name":"Halima Giwa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giwa, Halima","raw_affiliation_strings":["Department of Pharmacoeconomics and Pharmaceutical Management, Theran University of Medical Sciences, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacoeconomics and Pharmaceutical Management, Theran University of Medical Sciences, Iran","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069834320","display_name":"Muslim Olakunle Jamiu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134542131","display_name":"University of Ilorin","ror":"https://ror.org/032kdwk38","country_code":"NG","type":"education","lineage":["https://openalex.org/I134542131"]}],"countries":["NG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jamiu, Muslim","raw_affiliation_strings":["Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, University of Ilorin, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, University of Ilorin, Nigeria","institution_ids":["https://openalex.org/I134542131"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14334","display_name":"HIV/AIDS Impact and Responses","score":0.6294000148773193,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T14334","display_name":"HIV/AIDS Impact and Responses","score":0.6294000148773193,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.34619998931884766,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-aids","display_name":"HIV/AIDS","score":0.9829999804496765},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.9929999709129333},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/antiretroviral-drug-costs","display_name":"antiretroviral drug costs","score":0.9079999923706055},{"id":"https://openalex.org/keywords/direct-medical-costs","display_name":"direct medical costs","score":0.8180000185966492},{"id":"https://openalex.org/keywords/nigeria","display_name":"Nigeria","score":0.453000009059906},{"id":"https://openalex.org/keywords/developing-countries","display_name":"developing countries","score":0.7160000205039978},{"id":"https://openalex.org/keywords/health-care-expenditure","display_name":"health care expenditure","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6894000172615051},{"id":"https://openalex.org/C83864248","wikidata":"https://www.wikidata.org/wiki/Q177323","display_name":"Developing country","level":2,"score":0.6456000208854675},{"id":"https://openalex.org/C127598652","wikidata":"https://www.wikidata.org/wiki/Q558635","display_name":"Per capita","level":3,"score":0.6251999735832214},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5081999897956848},{"id":"https://openalex.org/C2983335822","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost analysis","level":2,"score":0.43130001425743103},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.428600013256073},{"id":"https://openalex.org/C140779682","wikidata":"https://www.wikidata.org/wiki/Q210868","display_name":"Sampling (signal processing)","level":3,"score":0.41839998960494995},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.4133000075817108},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.3926999866962433},{"id":"https://openalex.org/C182299520","wikidata":"https://www.wikidata.org/wiki/Q1289588","display_name":"Total cost","level":2,"score":0.3781999945640564},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3598000109195709},{"id":"https://openalex.org/C2780958618","wikidata":"https://www.wikidata.org/wiki/Q945621","display_name":"Average cost","level":2,"score":0.35409998893737793},{"id":"https://openalex.org/C145096142","wikidata":"https://www.wikidata.org/wiki/Q5333450","display_name":"Economic cost","level":2,"score":0.3528999984264374},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35010001063346863},{"id":"https://openalex.org/C68359772","wikidata":"https://www.wikidata.org/wiki/Q185715","display_name":"Opportunity cost","level":2,"score":0.34290000796318054},{"id":"https://openalex.org/C6964187","wikidata":"https://www.wikidata.org/wiki/Q659256","display_name":"Indirect costs","level":2,"score":0.33500000834465027},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.33169999718666077},{"id":"https://openalex.org/C3018457394","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral drug","level":5,"score":0.31709998846054077},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.3109000027179718},{"id":"https://openalex.org/C160050368","wikidata":"https://www.wikidata.org/wiki/Q132453","display_name":"Developed country","level":3,"score":0.30489999055862427},{"id":"https://openalex.org/C192489979","wikidata":"https://www.wikidata.org/wiki/Q1502997","display_name":"Systematic sampling","level":2,"score":0.3009999990463257},{"id":"https://openalex.org/C515549039","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost-effectiveness analysis","level":3,"score":0.29490000009536743},{"id":"https://openalex.org/C133462117","wikidata":"https://www.wikidata.org/wiki/Q4929239","display_name":"Data collection","level":2,"score":0.275299996137619},{"id":"https://openalex.org/C186079640","wikidata":"https://www.wikidata.org/wiki/Q719602","display_name":"Prevalence","level":3,"score":0.2741999924182892},{"id":"https://openalex.org/C95821633","wikidata":"https://www.wikidata.org/wiki/Q973302","display_name":"Cost driver","level":2,"score":0.26840001344680786},{"id":"https://openalex.org/C2985697011","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economic analysis","level":2,"score":0.2635999917984009},{"id":"https://openalex.org/C93983250","wikidata":"https://www.wikidata.org/wiki/Q795053","display_name":"Cost estimate","level":2,"score":0.2567000091075897},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.2554999887943268},{"id":"https://openalex.org/C15716912","wikidata":"https://www.wikidata.org/wiki/Q5174768","display_name":"Cost database","level":2,"score":0.2531999945640564}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.82351/wajp.vol29no2.465","doi":"https://doi.org/10.82351/wajp.vol29no2.465","is_oa":true,"landing_page_url":"https://doi.org/10.82351/wajp.vol29no2.465","pdf_url":null,"source":{"id":"https://openalex.org/S7407060212","display_name":"West African Journal of Pharmacy","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4391012544","host_organization_name":"Afrischolar Discovery Initiative","host_organization_lineage":["https://openalex.org/I4391012544"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.82351/wajp.vol29no2.465","doi":"https://doi.org/10.82351/wajp.vol29no2.465","is_oa":true,"landing_page_url":"https://doi.org/10.82351/wajp.vol29no2.465","pdf_url":null,"source":{"id":"https://openalex.org/S7407060212","display_name":"West African Journal of Pharmacy","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4391012544","host_organization_name":"Afrischolar Discovery Initiative","host_organization_lineage":["https://openalex.org/I4391012544"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2767037400","https://openalex.org/W2118525376","https://openalex.org/W2343471070","https://openalex.org/W2479847081","https://openalex.org/W2019559336","https://openalex.org/W1970698856","https://openalex.org/W2039858205","https://openalex.org/W4311334918","https://openalex.org/W2020886954","https://openalex.org/W4205897168"],"abstract_inverted_index":{"Background:":[0],"Highly":[1],"Active":[2],"Antiretroviral":[3],"Therapy":[4],"is":[5,191],"for":[6,123,199],"lifetime":[7],"of":[8,13,15,37,40,53,56,75,105,121,146,167,169,179,181,185,197],"the":[9,27,100,124],"patients":[10,127],"from":[11,62,72,99],"time":[12],"diagnosis":[14],"HIV/AIDS.":[16],"This":[17,190],"translates":[18],"into":[19],"a":[20,43,203],"substantial":[21],"cost":[22,36,120,144,166,178,196],"in":[23,42,46,79,201],"drug":[24],"therapy":[25,132],"to":[26,64,95],"patients,":[28],"government":[29],"and":[30,93,142,158],"donor":[31],"agencies.":[32],"Objective:":[33],"To":[34],"conduct":[35],"illness":[38,122,168,180,198],"analysis":[39],"HIV/AIDS":[41,58,126,170,182,200],"Developing":[44],"Economy":[45],"2016.":[47],"Methods:":[48],"A":[49,87],"one-year":[50],"retrospective":[51],"review":[52],"2560":[54],"prescriptions":[55],"396":[57,125],"patients'":[59],"case":[60,102],"notes":[61],"January":[63],"December,":[65],"2016":[66],"obtained":[67],"by":[68,109],"systematic":[69],"random":[70],"sampling":[71],"4800":[73],"case-notes":[74],"subjects":[76],"that":[77],"participated":[78],"this":[80],"study":[81],"was":[82,91,107,133,171],"conducted.":[83],"Sampling":[84],"Interval":[85],"=10":[86],"data":[88,97],"collection":[89],"form":[90],"designed":[92],"used":[94],"collect":[96],"generated":[98],"selected":[101],"notes.":[103],"Cost":[104],"Illness":[106],"determined":[108],"prevalence":[110],"rate":[111],"method,":[112],"using":[113],"direct":[114],"costs":[115],"only.":[116],"Results:":[117],"The":[118,163,175,193],"annual":[119,164,176,186],"on":[128],"highly":[129],"active":[130],"antiretroviral":[131],"?40,674,760":[134],"(US$127,108.3)":[135],"with":[136],"drug,":[137],"diagnostic/monitoring":[138],"tests,":[139],"transport,":[140],"care/support":[141],"personnel":[143],"components":[145],"?25,479,760;":[147],"US$79,624.3":[148],"(62.64%),":[149],"?7,200,000;":[150],"US$22,500":[151],"(17.71%),":[152],"?1,440,000;":[153],"US$4,500(3.54%),":[154],"?2,880,000;":[155],"US$9,000":[156],"(7.08%)":[157],"?3,675,000;":[159],"US$11484":[160],"(9.03%)":[161],"respectively.":[162],"average":[165,177],"?102,714.04":[172],"(US$320.98)":[173],"Conclusion:":[174],"represent":[183],"97%":[184],"per":[187],"capita":[188],"income.":[189],"enormous.":[192],"Annual":[194],"National":[195],"Nigeria,":[202],"developing":[204],"economy":[205],"may":[206],"be":[207],"about":[208],"N590":[209],"billion":[210],"annually.":[211]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7165452002","counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2026-06-21T00:00:00"}
